The latter is of particular interest due to its evidenced effect in animal models on reducing fat mass, improving lipid profile and insulin sensitivity, as well as its demonstrated neuroprotective activity [60,61,62], all key symptoms found in patients with ALMS and BBS syndromes. The gene discussed is INS; the disease is Bardet-Biedl syndrome.